HealthEquity Price Earnings Ratio from 2010 to 2024

HQY Stock  USD 104.25  0.40  0.38%   
HealthEquity Price Earnings Ratio yearly trend continues to be fairly stable with very little volatility. Price Earnings Ratio will likely drop to 72.27 in 2024. During the period from 2010 to 2024, HealthEquity Price Earnings Ratio regression line of annual values had r-squared of  0.01 and arithmetic mean of  78.72. View All Fundamentals
 
Price Earnings Ratio  
First Reported
2010-12-31
Previous Quarter
116.07781304
Current Value
72.27
Quarterly Volatility
192.1889859
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check HealthEquity financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among HealthEquity's main balance sheet or income statement drivers, such as Depreciation And Amortization of 160.7 M, Interest Expense of 58.2 M or Selling General Administrative of 108.8 M, as well as many indicators such as Price To Sales Ratio of 6.57, Dividend Yield of 0.0735 or PTB Ratio of 5.64. HealthEquity financial statements analysis is a perfect complement when working with HealthEquity Valuation or Volatility modules.
  
Check out the analysis of HealthEquity Correlation against competitors.
For more information on how to buy HealthEquity Stock please use our How to Invest in HealthEquity guide.

Latest HealthEquity's Price Earnings Ratio Growth Pattern

Below is the plot of the Price Earnings Ratio of HealthEquity over the last few years. It is HealthEquity's Price Earnings Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in HealthEquity's overall financial position and show how it may be relating to other accounts over time.
Price Earnings Ratio10 Years Trend
Very volatile
   Price Earnings Ratio   
       Timeline  

HealthEquity Price Earnings Ratio Regression Statistics

Arithmetic Mean78.72
Geometric Mean67.99
Coefficient Of Variation244.14
Mean Deviation96.29
Median64.45
Standard Deviation192.19
Sample Variance36,937
Range901
R-Value0.10
Mean Square Error39,365
R-Squared0.01
Significance0.72
Slope4.38
Total Sum of Squares517,112

HealthEquity Price Earnings Ratio History

2024 72.27
2023 116.08
2022 -196.55
2021 -100.31
2020 704.62
2019 111.63
2018 52.16

About HealthEquity Financial Statements

HealthEquity investors use historical fundamental indicators, such as HealthEquity's Price Earnings Ratio, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in HealthEquity. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Price Earnings Ratio 116.08  72.27 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for HealthEquity Stock Analysis

When running HealthEquity's price analysis, check to measure HealthEquity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HealthEquity is operating at the current time. Most of HealthEquity's value examination focuses on studying past and present price action to predict the probability of HealthEquity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HealthEquity's price. Additionally, you may evaluate how the addition of HealthEquity to your portfolios can decrease your overall portfolio volatility.